These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12544424)

  • 21. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.
    Huijberts MS; Wolffenbuttel BH; Boudier HA; Crijns FR; Kruseman AC; Poitevin P; Lévy BI
    J Clin Invest; 1993 Sep; 92(3):1407-11. PubMed ID: 8376593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.
    Corman B; Duriez M; Poitevin P; Heudes D; Bruneval P; Tedgui A; Levy BI
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1301-6. PubMed ID: 9448326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end products: a Nephrologist's perspective.
    Raj DS; Choudhury D; Welbourne TC; Levi M
    Am J Kidney Dis; 2000 Mar; 35(3):365-80. PubMed ID: 10692262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of the Maillard reaction on the physical properties and cell interactions of collagen.
    Avery NC; Bailey AJ
    Pathol Biol (Paris); 2006 Sep; 54(7):387-95. PubMed ID: 16962252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking.
    Choi SY; Chang HJ; Choi SI; Kim KI; Cho YS; Youn TJ; Chung WY; Chae IH; Choi DJ; Kim HS; Kim CH; Oh BH; Kim MH
    J Korean Med Sci; 2009 Feb; 24(1):32-9. PubMed ID: 19270810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
    Kass DA; Shapiro EP; Kawaguchi M; Capriotti AR; Scuteri A; deGroof RC; Lakatta EG
    Circulation; 2001 Sep; 104(13):1464-70. PubMed ID: 11571237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Advanced Glycation Endproducts in Rat Tail Collagen and Correlation to Tendon Stiffening.
    Jost T; Zipprich A; Glomb MA
    J Agric Food Chem; 2018 Apr; 66(15):3957-3965. PubMed ID: 29620898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.
    Wu ET; Liang JT; Wu MS; Chang KC
    Exp Gerontol; 2011 Jun; 46(6):482-8. PubMed ID: 21316441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue.
    Gautieri A; Passini FS; Silván U; Guizar-Sicairos M; Carimati G; Volpi P; Moretti M; Schoenhuber H; Redaelli A; Berli M; Snedeker JG
    Matrix Biol; 2017 May; 59():95-108. PubMed ID: 27616134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.
    Asif M; Egan J; Vasan S; Jyothirmayi GN; Masurekar MR; Lopez S; Williams C; Torres RL; Wagle D; Ulrich P; Cerami A; Brines M; Regan TJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2809-13. PubMed ID: 10706607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
    Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic cardiomyopathy: how much does it depend on AGE?
    Montagnani M
    Br J Pharmacol; 2008 Jun; 154(4):725-6. PubMed ID: 18414387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
    Wolffenbuttel BH; Boulanger CM; Crijns FR; Huijberts MS; Poitevin P; Swennen GN; Vasan S; Egan JJ; Ulrich P; Cerami A; Lévy BI
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4630-4. PubMed ID: 9539789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrosis, Enzymatic and Non-Enzymatic Cross-Links in Hypertensive Heart Disease.
    Ciulla MM; Paliotti R; Carini M; Magrini F; Aldini G
    Cardiovasc Hematol Disord Drug Targets; 2011; 11(2):61-73. PubMed ID: 22044034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.
    Liu J; Masurekar MR; Vatner DE; Jyothirmayi GN; Regan TJ; Vatner SF; Meggs LG; Malhotra A
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2587-91. PubMed ID: 12946933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation.
    Reihsner R; Melling M; Pfeiler W; Menzel EJ
    Clin Biomech (Bristol); 2000 Jun; 15(5):379-86. PubMed ID: 10758300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.
    Chang KC; Liang JT; Tsai PS; Wu MS; Hsu KL
    Br J Pharmacol; 2009 Aug; 157(8):1419-26. PubMed ID: 19681870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
    Yamagishi S
    Rejuvenation Res; 2012 Dec; 15(6):564-72. PubMed ID: 22950433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.